WHO世界卫生组织：单克隆抗体的临床研究景观-2014-2023年的报告（英文版）

Monoclonal antibodies (mAbs) are artificial proteins that mimic the body’s natural defences and represent an important medical innovation in modern medicine. They are of proven efficacy in various therapeutic areas such as cancer, immune diseases and infectious diseases, and have become the standard of care for several medical conditions in high-income countries, demonstrating improved outcomes over legacy treatments. This report uses data from WHO’s International Clinical Trials Registry Pla